SCHEMBL6206781

SCHEMBL6206781

C=C(N)C(=O)OC(=O)c1ccccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.50
SMN1; SMN2 Q16637 7/20 0.50
NPC1 O15118 5/20 0.50
HPGD P15428 4/20 0.50
PKM P14618 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
GAA P10253 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
ALDH1A1 P00352 3/20 0.46
POLB P06746 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MITF O75030 1/20 0.44
ESR1 P03372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207249 0.87 TSHR (0.49) RAB9ASMN1; SMN2NPC1HPGDPKM
SCHEMBL2153551 0.81 CES2 (0.62) RAB9ASMN1; SMN2NPC1HPGDPKM
SCHEMBL6207827 0.81 HPGD (0.52) RAB9ASMN1; SMN2NPC1HPGDL3MBTL1
SCHEMBL8925810 0.80 CES2 (0.52) RAB9ASMN1; SMN2NPC1HPGDPKM
SCHEMBL6205116 0.79 NPC1 (0.50) RAB9ASMN1; SMN2NPC1HPGDPKM
SCHEMBL6207031 0.79 CES2 (0.47) RAB9ANPC1HPGDPKML3MBTL1
SCHEMBL6208809 0.77 HPGD (0.51) RAB9ASMN1; SMN2NPC1HPGDL3MBTL1
SCHEMBL6205639 0.76 MAPT (0.43) RAB9ASMN1; SMN2NPC1L3MBTL1GAA
SCHEMBL6206850 0.76 LMNA (0.46) RAB9ANPC1L3MBTL1GAALMNA
SCHEMBL6206789 0.74 CTSD (0.50) RAB9ASMN1; SMN2NPC1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532128-A1 INHIBITORS OF HCV NS5B POLYMERASE Pharmacia & Upjohn Company LLC (US) 2005-05-25 EP disclosed
WO-2004002977-A1 INHIBITORS OF HCV NS5B POLYMERASE PHARMACIA & UPJOHN COMPANY LLC (US) 2004-01-08 WO disclosed